Cephalexin

Product NDC: 63187-287
11-digit product format: 631870287
Labeler code: 63187
Product ID: 63187-287_c6d27efc-fc18-487c-844f-b44e47b42b2d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Cephalexin
Dosage form: CAPSULE
Route: ORAL
Labeler: Proficient Rx LP
Application: ANDA062713
Marketing category: ANDA
Marketing start: 2012-01-12
Marketing end: 0000-00-00
Substance: CEPHALEXIN
Active strength: 250 mg/1
Pharmacologic classes: Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63187-287		D	Discontinued by firm	2026-08-17
excluded package	package	63187-287	63187-287-20	D	Discontinued by firm	2026-08-17
excluded package	package	63187-287	63187-287-28	D	Discontinued by firm	2026-08-17
excluded package	package	63187-287	63187-287-30	D	Discontinued by firm	2026-08-17
excluded package	package	63187-287	63187-287-40	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 60 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63187-287-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63187-287-20	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63187-287-40	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63187-287-28	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63187-287-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63187-287-20	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63187-287-40	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63187-287-28	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63187-287-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63187-287-20	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63187-287-40	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63187-287-28	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63187-287-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63187-287-20	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63187-287-40	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63187-287-28	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63187-287-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63187-287-20	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63187-287-40	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63187-287-28	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63187-287-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63187-287-20	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63187-287-40	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63187-287-28	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63187-287-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63187-287-20	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63187-287-40	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63187-287-28	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63187-287-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63187-287-20	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63187-287-40	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63187-287-28	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63187-287-30	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63187-287-20	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63187-287-40	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63187-287-28	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63187-287-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63187-287-20	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63187-287-40	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63187-287-28	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63187-287-30	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63187-287-20	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63187-287-40	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63187-287-28	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63187-287-30	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63187-287-20	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63187-287-40	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63187-287-28	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A062713-001	CEPHALEXIN	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB		1988-07-15
A062713-002	CEPHALEXIN	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB		1988-07-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A062713-001	AB
A062713-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A062713-001	CEPHALEXIN	EQ 250MG BASE	CAPSULE / ORAL	AB	1988-07-15	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A062713-002	CEPHALEXIN	EQ 500MG BASE	CAPSULE / ORAL	AB	1988-07-15	`bb7c543d1eb4…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A062713-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A062713-002	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A062713-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A062713-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062713-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A062713-002	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A062713-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A062713-002	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062713-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A062713-002	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062713-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A062713-002	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062713-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A062713-002	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062713-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A062713-002	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062713-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A062713-002	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062713-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A062713-002	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A062713-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A062713-002	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062713-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A062713-002	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062713-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A062713-002	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062713-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A062713-002	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A062713-001	AB	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A062713-002	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062713-001	AB	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A062713-002	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A062713-001	AB	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A062713-002	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A062713-001	AB	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A062713-002	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A062713-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A062713-002	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A062713-001	AB	1	`bb7c543d1eb4…`
2022-03-09 01:35 UTC	2022-03	A062713-002	AB	1	`bb7c543d1eb4…`

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CEPHALEXIN	ACTIVE INGREDIENT	OBN7UDS42Y	CEPHALEXIN CAPSULE [PROFICIENT RX LP]	2
CEPHALEXIN ANHYDROUS	ACTIVE MOIETY	5SFF1W6677	CEPHALEXIN CAPSULE [PROFICIENT RX LP]	2
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CEPHALEXIN CAPSULE [PROFICIENT RX LP]	2
GELATIN	INACTIVE INGREDIENT	2G86QN327L	CEPHALEXIN CAPSULE [PROFICIENT RX LP]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CEPHALEXIN CAPSULE [PROFICIENT RX LP]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	CEPHALEXIN CAPSULE [PROFICIENT RX LP]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	CEPHALEXIN CAPSULE [PROFICIENT RX LP]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cephalexin	CEPHALEXIN	AvKARE	03f6f6ae-66bc-6819-8ba9-7c9c3fbef90d	2026-07-29	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 062713 application number: ANDA062713